Organization legal form:
What is my fund looking for?:
We are looking for cutting-edge biotechnology with commercial interest outside the therapeutic area. Today our investments are in the sectors of agriculture, chemicals, foodtech, materials and nutrition, but we continue to expand. Ticket size can vary from early-stage seed investments (€1m) to growth equity (€100m).
About the Company
Novo Holdings is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation. In addition to being the major shareholder in the Novo Group companies (Novo Nordisk and Novozymes), Novo Holdings also invests the wealth of the foundation in life science (all stages of development). Headquartered in Copenhagen, with affiliates in San Francisco, Boston and Singapore, Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Share
Facebook
Twitter
LinkedIn
Telegram
Tumblr
WhatsApp
VK
Mail